Hysterectomy Clinical Trials

Clinical trials related to Hysterectomy Procedure

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Women With Adenomyosis-related Abnormal Uterine Bleeding Eligible for Hysterectomy: a Non-inferiority Randomized Clinical Trial Comparing Each Intervention to Hysterectomy

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 30
Maximum Age: 50
Healthy Volunteers: f
View:

• Premenopausal women aged 30 to 50 years

• Women who had at least 3 prior months failed medical therapy, or a contraindication to medical therapy, or refused medical therapy for adenomyosis-related AUB

• Symptomatic pure internal adenomyosis or dominant adenomyosis (with less than 5 concurrent uterine fibroids type 3-7 \< 5 cm) confirmed by MRI (\< 6 months) according to ESHRE criteria

• AUB defined as a PBAC score \>100 at baseline

• Uterine ultrasound measurement of 6.0-12.0 cm (external os to internal fundus)

• Women with an indication for hysterectomy for adenomyosis-related AUB and accepting hysterectomy

• Highly effective contraception for women of childbearing potential, maintained until the onset of menopause

• Affiliated or beneficiary of health insurance

• Signed informed consent

Locations
Other Locations
France
CHU Bordeaux
NOT_YET_RECRUITING
Bordeaux
APHP - Hôpital Antoine Béclère
NOT_YET_RECRUITING
Clamart
CHU Limoges
NOT_YET_RECRUITING
Limoges
CHU Montpellier
RECRUITING
Montpellier
Contact Information
Primary
Jean-Luc Brun, MD, PhD
jean-luc.brun@chu-bordeaux.fr
+33 5 56 79 59 85
Backup
Marc Sapoval, MD, PhD
marc.sapoval2@aphp.fr
+33 1 56 09 37 41
Time Frame
Start Date: 2026-04-17
Estimated Completion Date: 2029-05
Participants
Target number of participants: 230
Treatments
Experimental: Radiofrequency endometrial ablation
Radiofrequency endometrial ablation performed using NovaSure®
Experimental: Uterine artery embolization
Uterine artery embolization carried out under the guidance of digital subtraction angiography
Active_comparator: Hysterectomy
Hysterectomy
Related Therapeutic Areas
Sponsors
Collaborators: Ministry of Health, France
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov